Wilson Sonsini Goodrich & Rosati advised Doron Therapeutics on the transaction. Doron Therapeutics, a clinical-stage biotech company focusing on degenerative musculoskeletal conditions, announced it has raised...
Doron Therapeutics’ $11 Million Series A Financing Round
Faeth Therapeutics’ $47 Million Series A Financing
Wilson Sonsini advised Faeth Therapeutics on the deal. Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led...
KAP AG’s €125 Million Syndacated Financing
White & Case LLP has advised KAP AG, while Taylor Wessing, Meitar Law, Wilson Sonsini and Cuatrecasas advised Commerzbank AG on the deal. Commerzbank AG acted...
Enboarder’s $32 Million Series B Funding
Wilson Sonsini Goodrich & Rosati advised Enboarder on the deal. Enboarder, an employee engagement platform offering a unique “People Activation” approach to HR programs, announced it...
SEEIT’s $177 Million Acquisition of RED-Rochester
Wilson Sonsini Goodrich & Rosati advised SEEIT on the deal. SEEIT announced that it has agreed to acquire a 100 percent equity interest in a commercial...